Skip to content

the Research of the Cerebral Protection Effects of Electroencephalogram (SedLine) During Carotid Endarterectomy

Xuanwu Hospital Capital Medical University

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03622515
Enrollment
220
Registered
2018-08-09
Start date
2018-08-10
Completion date
2022-04-12
Last updated
2022-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Stroke, Postoperative Cognitive Dysfunction, Postoperative Delirium, Transient Ischemic Attack

Brief summary

Fragile brain is the most common phenomenon seen in the patients undergoing CEA. The patients with fragile brain have a high incidence of postoperative brain dysfunction. This study intends to apply EEG monitoring (Sedline) to CEA to investigate whether EEG monitoring can reduce the incidence of postoperative neurological complications in CEA patients and improve their prognosis. 220 patients with CEA were randomly divided into 2 groups. Group S \[Sedline monitoring + Transcranial Doppler (TCD) + regional cerebral oxygen saturation (rS02),n=110\] and group C \[Bispectral index (BIS)/Sedline monitoring + TCD +rSO2,n=110\], recording intraoperative and postoperative conditions, neuropsychology scale assessment, blood examination and imaging examination. The incidence of postoperative neurological complications was compared between the two groups.

Interventions

COMBINATION_PRODUCTAnesthesia level and cerebral perfusion pressure

Anesthetic dose and blood pressure

Sponsors

Beijing Municipal Administration of Hospitals
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

1. Patients undergoing elective carotid endarterectomy; 2. All those who agree to join the trial and sign the informed consent form; 3. ASAI to III.

Exclusion criteria

1. Those who refuse to sign the informed consent form; 2. ASA Level IV and above; 3. Unstable angina or acute myocardial infarction within 4 to 6 weeks before surgery, and heart function NYHA III to IV; 4. Those with severe liver and kidney function diseases; 5. Preoperative combined cognitive impairment; \[MMSE reference demarcation value: illiterate (uneducated) group ≤ 19 points, primary school (education years ≤ 6 years) group ≤ 22 points, secondary school or above (education years) 6 years) group ≤26 points; MoCA reference demarcation value: illiterate ≤13, primary school ≤19, middle school and above ≤24. \] 6. Preoperative combined anxiety and depression; (SDS or SAS\>41 points) 7. Patients with an endotracheal intubation returning to the ICU; 8. severe allergic reactions, major bleeding, etc. during surgery, causing severe fluctuations in hemodynamics; 9. The subject actively requested to withdraw from the study or to be lost to follow-up.

Design outcomes

Primary

MeasureTime frameDescription
the change from baseline of neurological complications before operationafter operationTransient ischemic attack, acute stroke, postoperative delirium, postoperative cognitive dysfunction, etc.

Secondary

MeasureTime frameDescription
the change from baseline of other complications before operation3 days after operationacute myocardial infarction, heart failure, arrhythmia, pulmonary infection, atelectasis, acute kidney injury, etc.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026